Open AccessHER2‑amplified metastatic lung adenocarcinoma responds to fourth‑line pyrotinib therapy: A case report
Author(s) -
Kan Gong,
Yi Yang,
Huan Huang,
Xunjie Kuang,
Xueqin Yang
Publication year - 2021
Publication title -
molecular and clinical oncology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2021.2375
Subject(s) - medicine , lapatinib , trastuzumab , oncology , nivolumab , adenocarcinoma , lung cancer , regimen , lung , cancer , chemotherapy , breast cancer , immunotherapy